MASTERCLASS MILAN 03/11/12 3 RD ESO-ESTRO MASTERCLASS IN RADIATION ONCOLOGY 3-8 November 2012 Milan, Italy Chair: M. Baumann, DE - J. Bernier, CH - R. Orecchia, IT R. Pötter, AT FIRST ANNOUNCEMENT
Aims and objectives Based on the success of the first and second Masterclass held in 2008 and 2010, ESO and ESTRO are pleased to announce the third edition. This intensive clinicallyoriented educational programme has been designed to offer a unique learning experience and to provide practice-oriented training to radiotherapists and to clinical oncologists with knowledge in the field. Teaching format The Masterclass offers plenary lectures focusing on the state-of-the-art treatments and concluding with take-home messages, full involvement of participants with case presentations, research proposals and interactive discussion with the faculty. All participants will reside at the course venue and their participation is compulsory throughout the course, with its approximately 30 hours of programme. The Masterclass will be entirely in English and fluency in English is compulsory for admission. The Masterclass is: A one-week residential educational event Full immersion Clinically- oriented Multidisciplinary, to cover pathology, staging and imaging, biology, physics, technologies with an overview on medical and surgical oncology An international faculty of experts will deliver lectures on principles of radiation oncology, head and neck, prostate, colorectal and lung cancers. Ideal Masterclass candidate Age between 30 and 45 years Knowledge and at least 3 years experience in clinical radiation oncology or medical oncologists with basic knowledge in radiotherapy Involvement in scientific activities Fluency in English Participation Attendance is limited to 50 participants and admittance is by competitive application only. Successful applicants are granted free registration but the costs for travel, accommodation and meals at the course venue (EUR 920), and the free dinners are to be covered by the participants. Accreditation Application for CME recognition will be submitted to the Accreditation Council for Oncology in Europe.
PRELIMINARY PROGRAMME OUTLINE SATURDAY, 3 NOVEMBER Arrivals General Session, part I Chair: M. Baumann, DE Recent radiobiological discoveries: Trends for translational research in the coming years Recent improvement in medical physics: Treatment planning and delivery Specific research designs for evidence-based radiation oncology I Specific research designs for evidence-based radiation oncology II Welcome drink and Dinner SUNDAY, 4 NOVEMBER General Session, part II Chair: M. Baumann, DE New systemic therapies from a medical oncologist s perspective New systemic therapies from a radiation oncologist s perspective Imaging in oncology: What can we really see today? Image guided radiotherapy Group sessions: Clinical cases and research proposals presented by the participants Free dinner
MONDAY, 5 NOVEMBER Non-small cell lung cancer session Chair: M. Baumann, DE Integrating biology in the treatment planning of lung cancer: Any options for therapeutic gain or dead end? Image guidance in decision making and radiotherapy of lung cancer Systemic treatments in NSCLC: What are we heading for? Multimodality in lung cancer: Do we really need a surgeon? Take-home messages Group sessions: Clinical cases and research proposals presented by the participants Free dinner TUESDAY, 6 NOVEMBER Prostate cancer session Chair: R. Pötter, AT Treatment decision, risk factors, nomograms and what else? Impact of imaging on treatment strategy and planning: Ultrasound, CT, MRI, PET-CT. What is necessary? And when? Evidence-based radical prostatectomy: Results and side effects in early and advanced disease How to understand the biology of radiation effects in various risk settings and treatment schedules: From low risk to high risk tumors, from low dose rate to high dose fraction 3D-CRT, IMRT, IGRT and more? From progress in technology to progress in outcome Image guided LDR and HDR brachytherapy: Potential and evidence; mono-therapy and combination treatment Take-home messages
Bus transfer to CNAO (National Center of Oncological Adrotherapy) in Pavia: Session: Critical appraisal of new technologies Optional guided visit to CNAO or free time Dinner off-site WEDNESDAY, 7 NOVEMBER Head and neck cancer session Chair: J. Bernier, CH Pathology of head and neck cancers: Towards the molecular era Organ preservation vs primary surgery: When, for whom? From biology to physics and clinical radiotherapy: How to integrate the recent translational research findings in clinics? Systemic treatments in head and neck oncology: What are we heading for? Take home messages Group sessions: Clinical cases and research proposals presented by the participants Dinner at the venue THURSDAY, 8 NOVEMBER Colorectal cancer session Chair: R. Orecchia, IT Evidences and perspectives in clinical staging The multidisciplinary approach to rectal cancer: Evidences and disagreements What do best treatment techniques mean nowadays? Perspectives in the combination with new drugs Take-home messages Departures
GENERAL INFORMATION FOR INFORMATION CONTACT: Chiara Gasparotto European School of Radiotherapy ESTRO Office Av. E. Mounier 83 1200 Brussels, Belgium Tel. +32 2 775 9337 Fax : +32 2 779 5494 e-mail cgasparotto@estro.org ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY APPLICATION DEADLINE: 30 JUNE 2012 Information and application form available at: www.eso.net or www.estro.org HOW TO APPLY Interested radiotherapists or clinical oncologists with knowledge in radiation therapy should fill in the Application form (available at www.eso.net or at www.estro.org) and provide: Letter describing motivation for attending Supporting letter from head of department or mentor CV with a list of publications An abstract on a clinical case and a research proposal (see below) relating to one of the subjects of the Masterclass (head and neck, prostate, colorectal, lung cancers) The abstract (max 1 page) should describe a clinical case in the form of a clinical grand-round with: Diagnostic considerations Treatment Result (follow up) At least three questions proposed for discussion with the faculty The research proposal (max 1 page)should not be a protocol but a description of an interesting future research perspective relating to one of the subjects of the Masterclass (colorectal, head and neck, lung or prostate cancer). The recommended structure of the proposal is as follows: Background Research questions / hypothesis Method of research Material to be investigated Expected results and potential conclusions After the selection, admitted participants will be scheduled to present either the clinical case or the research proposal during the group sessions of the Masterclass.